Addressing Failures in Life Sciences Projects

This document is a report that examines the high failure rates of mission-critical projects within the life sciences industry. It presents findings from a survey conducted by RGP, which indicates that only 13% of surveyed executives reported that all their projects met their goals since 2020. The report outlines the significant challenges faced by pharmaceutical, biotechnology, and medical device companies in managing complex projects, which include clinical trials, supply chain management, and mergers and acquisitions. It identifies a lack of project management expertise and strong leadership as central issues contributing to project failures. The report emphasizes the need for improved project management capabilities and centralized coordination of strategic initiatives. It also discusses the increasing reliance on external talent for project execution and the complexities that arise from managing diverse project teams. Recommendations for enhancing project success include establishing a centralized project management office and adopting a consistent project management methodology to improve efficiency and effectiveness.